234 related articles for article (PubMed ID: 26106616)
1. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation.
Futyma K; Miotła P; Gałczyński K; Baranowski W; Doniec J; Wodzisławska A; Jóźwik M; Oniszczuk M; Rechberger T
Biomed Res Int; 2015; 2015():851823. PubMed ID: 26106616
[TBL] [Abstract][Full Text] [Related]
2. Nonabsorbable urethral bulking agent - clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up.
Futyma K; Nowakowski Ł; Gałczyński K; Miotła P; Rechberger T
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():68-72. PubMed ID: 27825030
[TBL] [Abstract][Full Text] [Related]
3. Para-Urethral Injections with Urolastic® for Treatment of Female Stress Urinary Incontinence: Subjective Improvement and Safety.
de Vries AM; van Breda HMK; Fernandes JG; Venema PL; Heesakkers JPFA
Urol Int; 2017; 99(1):91-97. PubMed ID: 28152525
[TBL] [Abstract][Full Text] [Related]
4. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis.
Capobianco G; Azzena A; Saderi L; Dessole F; Dessole S; Sotgiu G
Int Urogynecol J; 2018 Sep; 29(9):1239-1247. PubMed ID: 29934769
[TBL] [Abstract][Full Text] [Related]
5. Results of an innovative bulking agent in patients with stress urinary incontinence who are not optimal candidates for mid-urethral sling surgery.
Kowalik CR; Casteleijn FM; van Eijndhoven HWF; Zwolsman SE; Roovers JWR
Neurourol Urodyn; 2018 Jan; 37(1):339-345. PubMed ID: 28452427
[TBL] [Abstract][Full Text] [Related]
6. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review.
Siddiqui ZA; Abboudi H; Crawford R; Shah S
Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200
[TBL] [Abstract][Full Text] [Related]
7. Urethral bulking agents for female stress urinary incontinence.
Hussain SM; Bray R
Neurourol Urodyn; 2019 Mar; 38(3):887-892. PubMed ID: 30801773
[TBL] [Abstract][Full Text] [Related]
8. [Transurethral injection of polyacrylamide hydrogel (Bulkamid®) for the treatment of female stress urinary incontinence and changes in the cure rate over time].
Martan A; Mašata J; Svabík K; El-Haddad R; Hubka P
Ceska Gynekol; 2013 Dec; 78(6):554-9. PubMed ID: 24372434
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of polydimethylsiloxane injection (Macroplastique
Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F;
BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026
[TBL] [Abstract][Full Text] [Related]
10. Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross-sectional study.
Casteleijn FM; Kowalik CR; Berends C; Blaganje M; Lasić Pecev M; van der Linden E; Zwolsman SE; Roovers JWR; Minnee P
Neurourol Urodyn; 2020 Aug; 39(6):1753-1763. PubMed ID: 32526063
[TBL] [Abstract][Full Text] [Related]
11. Can Urethral Bulking Agents Salvage Failed Slings?
Dray EV; Hall M; Covalschi D; Cameron AP
Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of periurethral injections of polyacrylamide hydrogel (Bulkamid(®)) and quality of life of patients with urinary incontinence due to sphincter deficiency (IUE-IS)].
Beraru A; Droupy S; Wagner L; Soustelle L; Muyschondt C; Ben Naoum K; Grés P; Boukaram M; Costa P
Prog Urol; 2014 Jun; 24(8):501-10. PubMed ID: 24875569
[TBL] [Abstract][Full Text] [Related]
13. [Bladder injury during sling operation in the treatment of SUI--review of literature and case report].
Gałczyński K; Futyma K; Bar K; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):784-8. PubMed ID: 23383566
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection.
Koski ME; Enemchukwu EA; Padmanabhan P; Kaufman MR; Scarpero HM; Dmochowski RR
Urology; 2011 May; 77(5):1076-80. PubMed ID: 21216448
[TBL] [Abstract][Full Text] [Related]
15. Management of recurrent stress urinary incontinence after burch and sling procedures.
Zimmern PE; Gormley EA; Stoddard AM; Lukacz ES; Sirls L; Brubaker L; Norton P; Oliphant SS; Wilson T
Neurourol Urodyn; 2016 Mar; 35(3):344-8. PubMed ID: 25598512
[TBL] [Abstract][Full Text] [Related]
16. Transurethral polydimethylsiloxane implantation: a valid option for the treatment of stress urinary incontinence due to intrinsic sphincter deficiency without urethral hypermobility.
Zullo MA; Plotti F; Bellati F; Muzii L; Angioli R; Panici PB
J Urol; 2005 Mar; 173(3):898-902. PubMed ID: 15711314
[TBL] [Abstract][Full Text] [Related]
17. Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women.
ter Meulen PH; Berghmans LC; Nieman FH; van Kerrebroeck PE
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Feb; 20(2):177-83. PubMed ID: 18936867
[TBL] [Abstract][Full Text] [Related]
18. Urolastic-a new bulking agent for the treatment of women with stress urinary incontinence: outcome of 12 months follow up.
Zajda J; Farag F
Adv Urol; 2013; 2013():724082. PubMed ID: 24454351
[TBL] [Abstract][Full Text] [Related]
19. Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.
Davis NF; Kheradmand F; Creagh T
Int Urogynecol J; 2013 Jun; 24(6):913-9. PubMed ID: 23224022
[TBL] [Abstract][Full Text] [Related]
20. Injection therapy for stress urinary incontinence in adult women.
ter Meulen H; van Kerrebroeck E
Expert Rev Med Devices; 2004 Nov; 1(2):205-13. PubMed ID: 16293041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
